Back to Investors
II

Infection Innovation Consortium

Government

The Infection Innovation Consortium is a global centre for infectious disease research and development.

Portfolio

1

companies


Portfolio companies

CP

CCI Photonics

CCI Photonics develops rapid diagnostic devices for infectious diseases.


Recent investments

Seed
£450K

The funding was backed by investors including Lyva Labs and the Northern Powerhouse Investment Fund II.

"This funding allows us to take critical steps in validating and refining our technology. With the support of our partners, we are working to bring a practical solution to healthcare challenges. The collaboration between Lancaster University and Morecambe Bay NHS Foundation Trust laid the foundation for this innovation."
— Carlos Alejandro Meza Ramirez, CEO